Navigation Links
Radyalis Announces Next Generation Of Monte Carlo Proton Therapy Planning For Advanced Radiation Cancer Treatment
Date:7/18/2014

AUSTIN, Texas, July 18, 2014 /PRNewswire-iReach/ -- Radyalis, a leader in advanced particle therapy software, will be showcasing its high performance Monte Carlo dose calculation product for proton applications simultaneously with the 2014 American Association of Physics in Medicine (AAPM) annual meeting in Austin, TX.

Radyalis breakthroughs in large-scale optimization and high-performance computing, enables for the first time clinicians to utilize the high accuracy benefits of Monte Carlo at unprecedented speeds for proton therapy dose modeling. The Radyalis Monte Carlo engine fundamentally changes today's radiotherapy workflow as the most complex patient treatment plans can be evaluated for efficacy and biological safety with high confidence in a matter of minutes.

Radyalis technology combines new algorithmic and software architecture advances for very high parallel efficiency on customer's existing hardware including single and multiple node installations, clusters, and cloud platforms, for both Linux and Windows environments.  Radyalis software is highly portable and very flexible, and designed to be integrated via a customer API or into a treatment planner.

Without compromise, Radyalis Monte Carlo supports a robust set of features. All relevant physics are accurately modeled. Simulation of complex geometries, NIST materials, and multiple beams are fully supported. Radyalis provides sophisticated dosage statistics including particle distributions, variability, fluence, and linear energy transfer, further guiding the radiation physicist.

The Radyalis fast and accurate Monte Carlo dose calculator is a key enabler for next-generation treatment plan optimization, robust planning, quality assurance, and ultimately real-time adaptive planning.  The speed and accuracy of Radyalis' Monte Carlo product provides significant ROI advantages for equipment manufacturers, treatment centers, and research organizations.

ABOUT RADYALIS

Radyalis develops and markets high performance software for radiotherapy applications that enable next-generation treatment planning and patient workflow. Based in Austin, Texas, the Radyalis team collectively brings 60+ years of related research and development experience to the particle therapy arena with focus on ultra-fast and accurate scanning-beam proton applications with extensions to other particle therapy methods. Radyalis has deep collaborations with premier oncology research hospitals and is committed to fundamentally impacting the accuracy, productivity, and cost of treatment planning through the increased use of automation.

RELATED LINKS:

http://radyalis.com

Media Contact: David LaPotin, Radyalis, 512-333-1619, david.lapotin@radyalis.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Radyalis
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Richmond Private Equity Group announces joint venture with Taking You Forward Inc.
2. Depomed Announces District Court Order in ANDA Litigation
3. Amgen Announces Positive Phase 3 Results for AMG 416 for the Treatment of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease Receiving Hemodialysis
4. JDRF Partner ViaCyte Announces Key Project Milestone to Advance Innovative Encapsulated Cell Replacement Therapy Product for Type 1 Diabetes
5. Fragile Kids Foundation Announces $125,000 Grant from the James M. Cox Foundation
6. BioLife Solutions Announces Manufacturing Agreement With Somahlution LLC
7. Encapsula NanoSciences Announces Release of Two New Products
8. Contract Research Organization WCCT Global Announces Huge Success in Large Phase I Clinical Research Program
9. Webcast Alert: Heska Announces Second Quarter 2014 Earnings Conference Call Webcast
10. CVS Caremark Announces New Clinical Affiliations with Four Major Health Care Providers
11. Seres Health Completes Enrollment in a Clinical Study for SER-109 in Recurrent Clostridium difficile Infection and Announces Positive Preliminary Data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
Breaking Medicine News(10 mins):